IL182462A0 - Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone - Google Patents
Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisoneInfo
- Publication number
- IL182462A0 IL182462A0 IL182462A IL18246207A IL182462A0 IL 182462 A0 IL182462 A0 IL 182462A0 IL 182462 A IL182462 A IL 182462A IL 18246207 A IL18246207 A IL 18246207A IL 182462 A0 IL182462 A0 IL 182462A0
- Authority
- IL
- Israel
- Prior art keywords
- days
- prednisone
- treatment
- leukemia
- graft
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title abstract 3
- 208000024908 graft versus host disease Diseases 0.000 title abstract 2
- 208000032839 leukemia Diseases 0.000 title abstract 2
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 title abstract 2
- 229960004618 prednisone Drugs 0.000 title abstract 2
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 title 1
- 208000009329 Graft vs Host Disease Diseases 0.000 title 1
- 229950000210 beclometasone dipropionate Drugs 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 238000011260 co-administration Methods 0.000 abstract 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 abstract 1
- 239000012729 immediate-release (IR) formulation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Surgery (AREA)
- Endocrinology (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64017804P | 2004-12-30 | 2004-12-30 | |
| PCT/US2005/047666 WO2006072093A2 (en) | 2004-12-30 | 2005-12-30 | Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL182462A0 true IL182462A0 (en) | 2008-04-13 |
Family
ID=36615583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL182462A IL182462A0 (en) | 2004-12-30 | 2007-04-11 | Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060252735A1 (https=) |
| EP (1) | EP1830857B1 (https=) |
| JP (1) | JP2008526773A (https=) |
| KR (1) | KR20070089701A (https=) |
| CN (2) | CN101060848B (https=) |
| AT (1) | ATE481102T1 (https=) |
| AU (1) | AU2005321826B2 (https=) |
| CA (1) | CA2583244A1 (https=) |
| DE (1) | DE602005023655D1 (https=) |
| DK (1) | DK1830857T3 (https=) |
| IL (1) | IL182462A0 (https=) |
| NZ (1) | NZ554326A (https=) |
| WO (1) | WO2006072093A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090143328A1 (en) * | 2001-08-13 | 2009-06-04 | Mcdonald George | Method of Treating Cancer by Administration of Topical Active Corticosteroids |
| SG10201704531XA (en) * | 2008-12-08 | 2017-07-28 | Soligenix Inc | Topically active steroids for use in radiation and chemotherapeutics injury |
| US20170209447A1 (en) * | 2014-08-07 | 2017-07-27 | Nitor Therapeutics | Use of PNP Inhibitor to Treat Relapse of Malignancy after Hematopoietic Stem Cell Transplant |
| CN106236736A (zh) * | 2016-09-26 | 2016-12-21 | 安徽省逸欣铭医药科技有限公司 | 二丙酸倍氯米松肠溶缓释片及其制备方法 |
| EP4073100A4 (en) | 2019-12-09 | 2024-02-14 | Syndax Pharmaceuticals, Inc. | ANTIBODIES FOR TREATING CHRONIC GRAFT VERSUS HOST DISEASE |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096728A (en) * | 1996-02-09 | 2000-08-01 | Amgen Inc. | Composition and method for treating inflammatory diseases |
| US5747474A (en) * | 1996-07-29 | 1998-05-05 | Immune Modulation, Inc. | Immunosuppression by administration of N6,N6 -disubstituted cAMP's, analogues thereof, and related nucleosides |
| US6096731A (en) * | 1998-06-24 | 2000-08-01 | Institute For Drug Research, Inc. | Method for preventing tissue damage associated with graft-versus-host or host-versus-graft disease following transplantation |
| US20020086857A1 (en) * | 2000-09-15 | 2002-07-04 | Mcdonald George B. | Method of long-term treatment of graft-versus-host disease using topical active corticosterioids |
| AU2002254205B2 (en) * | 2001-03-15 | 2007-05-10 | Enteron Pharmaceuticals, Inc. | Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
| US20030032631A1 (en) | 2001-08-13 | 2003-02-13 | Mcdonald George B. | Method of treatment of cancer by controlling graft-versus-leukemia using topical active corticosteriods |
| JP4014912B2 (ja) * | 2001-09-28 | 2007-11-28 | 株式会社ルネサステクノロジ | 半導体装置 |
-
2005
- 2005-12-30 JP JP2007549693A patent/JP2008526773A/ja active Pending
- 2005-12-30 CN CN2005800393955A patent/CN101060848B/zh not_active Expired - Fee Related
- 2005-12-30 CA CA002583244A patent/CA2583244A1/en not_active Abandoned
- 2005-12-30 AT AT05856121T patent/ATE481102T1/de not_active IP Right Cessation
- 2005-12-30 EP EP05856121A patent/EP1830857B1/en not_active Expired - Lifetime
- 2005-12-30 DE DE602005023655T patent/DE602005023655D1/de not_active Expired - Lifetime
- 2005-12-30 DK DK05856121.8T patent/DK1830857T3/da active
- 2005-12-30 AU AU2005321826A patent/AU2005321826B2/en not_active Ceased
- 2005-12-30 NZ NZ554326A patent/NZ554326A/en not_active IP Right Cessation
- 2005-12-30 KR KR1020077013835A patent/KR20070089701A/ko not_active Ceased
- 2005-12-30 US US11/320,564 patent/US20060252735A1/en not_active Abandoned
- 2005-12-30 WO PCT/US2005/047666 patent/WO2006072093A2/en not_active Ceased
- 2005-12-30 CN CN2011101121156A patent/CN102218070A/zh active Pending
-
2007
- 2007-04-11 IL IL182462A patent/IL182462A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006072093A3 (en) | 2007-03-22 |
| CN101060848A (zh) | 2007-10-24 |
| EP1830857B1 (en) | 2010-09-15 |
| EP1830857A4 (en) | 2008-02-27 |
| KR20070089701A (ko) | 2007-08-31 |
| DK1830857T3 (da) | 2011-02-07 |
| EP1830857A2 (en) | 2007-09-12 |
| NZ554326A (en) | 2010-10-29 |
| ATE481102T1 (de) | 2010-10-15 |
| AU2005321826A1 (en) | 2006-07-06 |
| CA2583244A1 (en) | 2006-07-06 |
| JP2008526773A (ja) | 2008-07-24 |
| AU2005321826B2 (en) | 2012-03-15 |
| US20060252735A1 (en) | 2006-11-09 |
| WO2006072093A2 (en) | 2006-07-06 |
| DE602005023655D1 (de) | 2010-10-28 |
| CN101060848B (zh) | 2011-06-22 |
| CN102218070A (zh) | 2011-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200806318A (en) | Uses of anti-insulin-like growth factor I receptor antibodies | |
| NZ606825A (en) | Methods and compositions for treating complement-associated disorders | |
| WO2005034843A3 (en) | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders | |
| RU2012106620A (ru) | Комбинации и способы введения терапевтических средств и комбинированной терапии | |
| IL182462A0 (en) | Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone | |
| JP2016509050A5 (https=) | ||
| WO2006047593A3 (en) | Method of potentiating inflammatory and immune modulation for cell and drug therapy | |
| WO2006022612A3 (en) | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders | |
| MY166524A (en) | Therapeutic substance, pharmaceutical composition, helicobacter pylori growth inhibitor and method for conducting anti-helicobacter therapy | |
| MX2022016410A (es) | Metodos para tratar el cancer o enfermedad de von-hippel lindau usando una combinacion de un antagonista del pd-1, inhibidor de hif-2 alpha y lenvatinib o una sal aceptable farmeuticamente de estos. | |
| CA2595363A1 (en) | Methods and materials with trans-clomiphene for the treatment of male infertility | |
| MXPA05010804A (es) | Torio 227 para uso en radioterapia de enfermedades del tejido blando. | |
| MY148085A (en) | Treatment of graft-versus-host disease and leukemia with beclomethasone dipropionate and prednisone | |
| Anzalone et al. | Oroantral communication as an osteotome sinus elevation complication | |
| Boer et al. | Four‐day quadruple therapy as a routine treatment for Helicobacter pylori infection | |
| CN104324018B (zh) | 广藿香醇在制备男性性功能障碍药物或保健品中的应用 | |
| MX2012005497A (es) | Tivozanib y temsirolimus en combinacion. | |
| WO2008143014A1 (ja) | がん治療剤 | |
| MX2022012519A (es) | Endoxifeno para el tratamiento del trastorno bipolar i. | |
| JP2012025734A (ja) | 骨髄異形性症候群を治療するための組成物および方法 | |
| Bhat et al. | Therapeutic modalities in the management of COVID-19: a worldwide landscape | |
| WO2023225630A3 (en) | FORMULATIONS FOR ADMINISTERING LAAM, norLAAM AND dinorLAAM AND METHODS OF THEIR USE TO TREAT OPIOID USE DISORDER | |
| Rongvaux-Gaïda et al. | Best Administration Schedule for Optimal Efficacy and Safety of Arsenic Trioxide Treatment in Chronic Graft versus Host Disease | |
| CN108778310A (zh) | 造血干细胞移植患者的处理 | |
| Starr | Gilteritinib a New Standard of Care for Relapsed or Refractory AML with FLT3 Mutation. |